Lataa...
Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C
Chronic infection with hepatitis C virus (HCV) affects an estimated 0.1%–2% of the pediatric population in the United States. While the clinical course in young children is indolent, adolescents who contract HCV have a disease course similar to adults, with a 26-fold increased risk of chronic liver...
Tallennettuna:
| Julkaisussa: | Adolesc Health Med Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6071628/ https://ncbi.nlm.nih.gov/pubmed/30104913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/AHMT.S147896 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|